![Magnifying glass held over paper butterfly](/files/default/2019-03/our-vision-slim-banner_2.jpg)
Santen facts and figures
![€1.87 billion](/files/default/2019-04/santen-facts-1%402x_0.png)
€1.87 billion revenue
(approx. 266.3 billion yen)
![94% of revenue from prescription ophthalmic pharmaceuticals](/files/default/2019-04/santen-facts-2%402x.png)
94% of revenue from prescription ophthalmic pharmaceuticals
![Overseas sales accounts for 35%](/files/default/2019-04/santen-facts-3%402x.png)
Sales outside Japan account for 35% of corporate revenue
![4,300 employees globally](/files/default/2019-04/santen-facts-6%402x.png)
4,300 employees globally
![Products supplied in over 60 countries and regions](/files/default/2020-02/santen-products-supplied.png)
Products supplied in over 60 countries and regions
![Dedicated facility for ongoing research and development](/files/default/2019-07/santen-facts-dedicated-facilities.jpg)
Dedicated facilities for ongoing research and development: Nara (Japan), Evry (France), Emeryville (US), etc.
![Three manufacturing sites](/files/default/2020-02/santen-three-sites.png)
Three manufacturing sites: Noto and Shiga (Japan), Suzhou (China)
Source: Santen Pharmaceutical Co., Ltd. Fiscal year (FY2021) ended 31 March 2022.